Pyridostigmine D6 Bromide
| Product Name | Pyridostigmine D6 Bromide |
|---|---|
| Alternate Names | Pyridostigmine Stable Isotopes, Stable Isotopes of Pyridostigmine |
| CAT No. | CS-O-06898 |
| CAS No. | 101-26-8(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 267.15 g/mol |
| Mol. For. | C₉H₇D₆BrN₂O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Pyridostigmine |
| Purity | Not less than 90 % |
| Smileys | O=C(N(C([2H])([2H])[2H])C([2H])([2H])[2H])OC1=C[N+](C)=CC=C1.[Br-] |
| Canonical Smiles | C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-] |
| InchIKey | VNYBTNPBYXSMOO-UHFFFAOYSA-M |
| Inchl | InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1 |
| IUPAC | (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Pyridostigmine D6 Bromide is a medication that is commonly used to treat myasthenia gravis, a neuromuscular disorder that causes muscle weakness and fatigue. This medication works by inhibiting the breakdown of acetylcholine, a neurotransmitter that is essential for muscle movement. By increasing the levels of acetylcholine in the body, Pyridostigmine D6 Bromide helps to improve muscle strength and function in individuals with myasthenia gravis.
Chemically, Pyridostigmine D6 Bromide is a quaternary ammonium compound that contains a pyridine ring. The "D6" in its name refers to the fact that it is a deuterated compound, meaning that some of its hydrogen atoms have been replaced with deuterium atoms. This modification is often made in order to enhance the stability and effectiveness of the medication.
Pyridostigmine D6 Bromide is typically administered orally, with dosages varying depending on the severity of the patient's condition. It is important to follow the prescribed dosage and instructions provided by a healthcare professional, as misuse or overuse of the medication can lead to adverse side effects.
Overall, Pyridostigmine D6 Bromide is a valuable medication for individuals with myasthenia gravis, helping to improve their quality of life and manage their symptoms. Its chemical properties and mechanisms of action make it an effective treatment option for this challenging condition.
Get an Instant Quote
Related Compounds
Pyridostigmine D3 Bromide |